Literature DB >> 9230236

Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo.

N Esmailpour1, P Högger, K F Rabe, U Heitmann, M Nakashima, P Rohdewald.   

Abstract

High retention of inhaled glucocorticoids in the airways means prolonged anti-inflammatory action and low delivery into the serum. The objective of this study was to investigate the retention in and distribution of inhaled fluticasone propionate (FP) between central and peripheral human lung tissue and serum in vivo. In 17 patients undergoing lung resection surgery, a single 1.0 mg dose of FP was inhaled at varying time-points (range 2.8-21.7 h) preoperatively. Peripheral and central lung tissue was obtained, and blood was drawn simultaneously. FP concentrations in central lung tissue were approximately three to four times higher than peripheral lung tissue concentrations, which in turn, exceeded those found in serum by 10 times. FP was detectable up to 21 and 16 h, respectively, after inhalation, with drug levels falling almost in parallel in peripheral lung tissue and in serum. The results of this study demonstrate that fluticasone propionate is retained in lung tissue for a long time. Serum concentrations after a single inhaled dose are low. Retention of high concentrations of fluticasone propionate in the airways may promote high topical anti-inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230236     DOI: 10.1183/09031936.97.10071496

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.

Authors:  R J Meijer; H A Kerstjens; L R Arends; H F Kauffman; G H Koëter; D S Postma
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.

Authors:  A Dijkstra; J M Vonk; H Jongepier; G H Koppelman; J P Schouten; N H T ten Hacken; W Timens; D S Postma
Journal:  Thorax       Date:  2005-11-24       Impact factor: 9.139

Review 3.  Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?

Authors:  Emir Festic; Paul D Scanlon
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

Review 4.  Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities.

Authors:  Donglu Zhang; Cornelis E C A Hop; Gabriela Patilea-Vrana; Gautham Gampa; Herana Kamal Seneviratne; Jashvant D Unadkat; Jane R Kenny; Karthik Nagapudi; Li Di; Lian Zhou; Mark Zak; Matthew R Wright; Namandjé N Bumpus; Richard Zang; Xingrong Liu; Yurong Lai; S Cyrus Khojasteh
Journal:  Drug Metab Dispos       Date:  2019-07-02       Impact factor: 3.922

5.  In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.

Authors:  Yi-Bo Wang; Alan B Watts; Jay I Peters; Sha Liu; Ayesha Batra; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2014-05-14       Impact factor: 3.246

Review 6.  Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

7.  Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.

Authors:  L Thorsson; S Edsbäcker; A Källén; C G Löfdahl
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

8.  Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study.

Authors:  Emir Festic; Vikas Bansal; Ognjen Gajic; Augustine S Lee
Journal:  Mayo Clin Proc       Date:  2014-02       Impact factor: 7.616

9.  Evidence of the in vivo esterification of budesonide in human airways.

Authors:  Karen I Maassen van den Brink; Martin Boorsma; A Jeske Staal-van den Brekel; Staffam Edsbäcker; Emiel F Wouters; Lars Thorsson
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

10.  New insights into the pathophysiology of the small airways in asthma.

Authors:  Qutayba Hamid; Meri K Tulic
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.